{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": "None",
    "classification": "non-complex",
    "supporting_data": "The JPM China A Research Enhanced Index Equity Active UCITS ETF is a UCITS-compliant ETF, which is automatically classified as non-complex under MiFID II Article 25(4)(a)(iv), unless it is a structured UCITS or fails the Article 57 criteria[1]. The fund's investment policy is to actively invest primarily in Chinese A-shares, aiming to outperform the MSCI China A Index. While the fund may use derivatives for efficient portfolio management (EPM), such use is limited and not central to the investment strategyu2014derivatives are not used for synthetic replication, leverage, or to achieve complex payoffs. The fund does not use swaps, does not employ leverage beyond UCITS limits, and does not invest in structured products like CLOs or contingent convertible bonds. The replication method is physical (holding underlying equities), not synthetic. The risks disclosed are typical for equity ETFs (market, currency, liquidity, concentration, ESG exclusions), with no mention of complex derivative structures, counterparty risk from swaps, or embedded options. The fund's structure, objective, and risks are transparent and can be understood by a retail investor with basic knowledge. There is no evidence of features that would trigger a complex classification under Article 57 (e.g., no frequent or material use of derivatives for replication, no complex indices, no contingent bonds, no significant securities lending increasing opacity). Therefore, the fund remains non-complex under MiFID II[1]."
}